| Dr Eric David Shapiro, DDS | |
|
5363 Balboa Blvd Ste 325, Encino, CA 91316-2807 | |
| (818) 788-1181 | |
| Not Available |
| Full Name | Dr Eric David Shapiro |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 5363 Balboa Blvd Ste 325, Encino, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538204896 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 036285 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric David Shapiro, DDS 5363 Balboa Blvd Ste 325, Encino, CA 91316-2807 Ph: (818) 788-1187 | Dr Eric David Shapiro, DDS 5363 Balboa Blvd Ste 325, Encino, CA 91316-2807 Ph: (818) 788-1181 |
News Archive
A new study suggests that lending conditions imposed by the International Monetary Fund in West Africa squeeze "fiscal space" in nations such as Sierra Leone - preventing government investment in health systems and, in some cases, contributing to an exodus of medical talent from countries that need it most.
Even as treatment options for laryngeal cancer seemed to improve, survival rates did not. For the most advanced patients, 50 percent survival was the norm, whether patients had surgery to totally remove the voice box or alternative treatment with chemotherapy and radiation to try to avoid surgery.
For years doctors have used the body mass index (BMI), a ratio of height and weight, to characterize the clinical weight status of their patients.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Roper Industries, Inc. announced today that its Senior Subordinated Convertible Notes due 2034 will accrue contingent interest for the period of July 16, 2010 to January 15, 2011 at an annual rate of 0.25% of the average market price of the Notes for the five trading days ended July 13, 2010.
› Verified 8 days ago
Dr. Lecia Erin Harmer, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 6345 Balboa Blvd Ste 314, Encino, CA 91316 Phone: 818-943-8228 Fax: 509-271-7372 | |
Jeremiah Beisel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 15720 Ventura Blvd Ste 301, Encino, CA 91436 Phone: 818-788-7181 Fax: 818-907-1891 | |
Mr. Steven Yoshiharu Shiba, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 16311 Ventura Blvd, #1075, Encino, CA 91436 Phone: 818-783-2770 Fax: 818-788-0494 | |
Roya Delafraz, Dentist Medicare: Not Enrolled in Medicare Practice Location: 15760 Ventura Blvd Ste 606, Encino, CA 91436 Phone: 818-981-9143 | |
Dr. Jeffrey B Ballen, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 5363 Balboa Blvd, Suite 534, Encino, CA 91316 Phone: 818-986-6777 | |
Dr. Richard Lee Kahn, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 16406 Moorpark St, Encino, CA 91436 Phone: 213-740-8084 | |
Dr. Kory Michael Zussman, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 16311 Ventura Blvd Ste 625, Encino, CA 91436 Phone: 818-907-1318 |